A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)

Altoona Center for Clinical Research, Duncansville

The Center for Rheumatology and Bone Research, Wheaton

Shelby Clinical Research, LLC, Shelby

Napa Research Center, Pompano Beach

GCP Clinical Research, Tampa

ProHealth Research Center, Doral

Biopharma Informatic, LLC, Houston

Arizona Arthritis & Rheumatology Research, PLLC, Glendale

East Bay Rheumatology Medical Group, Inc., San Leandro

Arthritis Clinic: Western Washington Medical Group, Bothell

Arthritis Northwest PLLC, Spokane

Orthopedic Physicians Alaska, Anchorage